Peneprin (75 mg Gastro-Resistant Tablet)

Enteric-coated (gastro-resistant) tablet containing peneprin — prescription medication

Rx – Prescription Only Enteric-Coated Tablet
Active Ingredient
Peneprin
Dosage Form
Gastro-resistant tablet
Strength
75 mg
Administration
Oral (swallow whole)
Medically reviewed | Last reviewed: | Evidence level: 1A
Peneprin is a prescription medication available as 75 mg gastro-resistant (enteric-coated) tablets. The active substance is peneprin. The enteric coating is designed so that the tablet passes intact through the stomach and releases the active ingredient in the small intestine. This medication should only be used under medical supervision and according to the directions of your prescribing healthcare provider. This guide provides comprehensive information about Peneprin, including how to take it, potential side effects, drug interactions, storage, and important precautions.
📅 Published:
🔄 Reviewed:
Reading time: 13 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in Clinical Pharmacology

Quick Facts About Peneprin

Active Ingredient
Peneprin
active substance
Available Form
Enteric Tablet
gastro-resistant
Strength
75 mg
per tablet
Administration
Oral
swallow whole
Prescription Status
Rx Only
prescription required
Brand Name
Peneprin
original brand

Key Takeaways About Peneprin

  • Prescription required: Peneprin is a prescription-only medication and must be used under medical supervision
  • Enteric-coated 75 mg tablets: The gastro-resistant coating releases the active substance in the small intestine rather than the stomach
  • Swallow whole: Never crush, split, chew, or break the tablet – this would destroy the protective coating
  • Follow your doctor's instructions: Always take Peneprin exactly as your healthcare provider has prescribed, at the same time each day
  • Report side effects and interactions: Tell your doctor about all other medications, supplements, and herbal remedies you are taking, and report any unexpected symptoms promptly

What Is Peneprin and What Is It Used For?

Peneprin is a prescription medication available as 75 mg gastro-resistant (enteric-coated) tablets containing the active substance peneprin. It is prescribed by healthcare providers based on the patient's individual medical needs and clinical assessment. The enteric coating is designed to release the active ingredient in the small intestine rather than the stomach.

Peneprin belongs to a class of pharmaceutical agents that are used under the direction of a qualified healthcare provider. As a prescription-only medication, it has undergone rigorous evaluation by regulatory authorities such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) to ensure its quality, safety, and efficacy before being made available to patients. Peneprin is formulated as a gastro-resistant (enteric-coated) tablet, a specialized oral dosage form used when the active substance would be degraded by stomach acid, when it would irritate the gastric mucosa, or when it is preferable to target drug release to the small intestine.

The active substance in Peneprin is peneprin, present at a concentration of 75 mg per tablet. Your doctor will determine whether Peneprin is the appropriate treatment for your condition after considering your medical history, current health status, and any other medications you may be taking. It is essential that you follow the prescribed dosage and treatment duration as directed by your healthcare provider, and that you do not stop taking Peneprin abruptly without medical advice, even if you feel better.

Like all prescription medications, Peneprin has been developed and tested according to strict pharmaceutical quality standards, including those published in the European Pharmacopoeia and the International Council for Harmonisation (ICH) guidelines. The gastro-resistant (enteric) coating uses polymers that remain intact in the low-pH environment of the stomach but dissolve once the tablet reaches the higher-pH environment of the small intestine. This property has two main clinical purposes: protecting the active ingredient from acid degradation and protecting the stomach lining from potential irritation caused by the active substance.

Because the enteric coating is essential to how Peneprin works, it is critical that tablets are swallowed whole. Crushing, cutting, or chewing an enteric-coated tablet would break the protective barrier, expose the active ingredient to stomach acid, and could either reduce effectiveness or increase the risk of gastrointestinal side effects. Patients who have difficulty swallowing tablets should discuss alternative dosage forms with their doctor rather than attempting to modify the Peneprin tablet themselves.

Important Information:

Peneprin is a prescription-only medication. Do not share this medicine with others, even if they appear to have similar symptoms. Your doctor has prescribed Peneprin specifically for you based on your individual medical needs. Always take it exactly as directed by your healthcare provider, and never attempt to crush, split, or chew the enteric-coated tablet.

What Should You Know Before Taking Peneprin?

Before starting Peneprin, inform your doctor about all medical conditions, allergies, and current medications. Certain conditions, including significant liver or kidney impairment and pre-existing gastrointestinal disorders, may require special monitoring or dose adjustments. Your healthcare provider will assess whether Peneprin is suitable for you.

A thorough pre-treatment assessment is an important part of safe prescribing. Your doctor will consider your complete medical history, current health status, concurrent medications, allergies, and lifestyle factors before initiating Peneprin. Providing accurate and complete information during this assessment helps minimize the risk of adverse effects and maximizes the likelihood of successful treatment. Never withhold information from your healthcare provider, even if you think it may be unrelated to the medication.

Contraindications

Do not take Peneprin if you are allergic (hypersensitive) to peneprin or any of the other ingredients in this medication. An allergic reaction may include symptoms such as skin rash, itching, swelling of the face, lips, tongue or throat, shortness of breath, or anaphylaxis. If you experience any of these symptoms, stop taking Peneprin and seek immediate medical attention by calling your local emergency number or visiting the nearest emergency department.

Your doctor will evaluate your medical history before prescribing Peneprin to ensure there are no contraindications. Patients with severe liver impairment, severe kidney impairment, or a history of gastrointestinal disease should discuss the risks and benefits of Peneprin with their healthcare provider, as dose adjustments or closer monitoring may be necessary. If you have previously experienced an allergic reaction to any medication with a similar chemical structure, inform your doctor, as cross-reactivity between related pharmaceutical compounds is possible.

Peneprin should generally not be used in patients with known swallowing difficulties that would prevent them from swallowing the tablet whole, because the enteric coating must remain intact for the medication to work correctly. If you have a condition such as dysphagia, oesophageal stricture, or gastroparesis, inform your healthcare provider so that alternative therapies can be considered if needed.

Warnings and Precautions

Talk to your doctor or pharmacist before taking Peneprin if any of the following conditions or circumstances apply to you:

  • Liver disease: Patients with hepatic impairment may require dose adjustments or more frequent monitoring of liver function tests (ALT, AST, bilirubin)
  • Kidney disease: Renal impairment may affect the elimination of peneprin and its metabolites, potentially requiring dose modification; your doctor may check your estimated glomerular filtration rate (eGFR)
  • Gastrointestinal disorders: Active peptic ulcer disease, gastro-oesophageal reflux, inflammatory bowel disease, or a history of GI bleeding may require additional precautions
  • Cardiovascular conditions: Inform your doctor if you have any cardiovascular disease, including heart failure, arrhythmias, uncontrolled hypertension, or a history of myocardial infarction
  • Elderly patients: Older adults may be more susceptible to side effects and often benefit from a lower starting dose with gradual titration
  • Other medications: Some drugs may interact with Peneprin, affecting how it works or increasing the risk of adverse effects (see the drug interactions section below)
  • Scheduled surgery: Inform surgeons, anaesthetists, and dentists that you are taking Peneprin before any planned procedure

Regular medical check-ups are recommended while taking Peneprin to monitor your response to the medication and detect any potential adverse effects early. Your doctor may order blood tests or other diagnostic assessments periodically to ensure the medication is working safely and effectively. Attend all scheduled appointments and report any unusual symptoms promptly between visits.

Do not stop taking Peneprin abruptly without consulting your doctor, even if you feel well. Stopping some medications suddenly can worsen the underlying condition or cause withdrawal-like symptoms. Your doctor will advise you on whether the medication can be stopped directly or whether the dose should be gradually reduced (tapered) over a period of days or weeks.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before taking Peneprin. The safety of Peneprin during pregnancy has not been fully established in large controlled studies. Your doctor will carefully weigh the potential benefits for you against the possible risks to the unborn child before prescribing this medication during pregnancy, and in many cases will prefer an alternative treatment when one is available.

It is not known whether peneprin passes into breast milk in clinically relevant amounts. If you are breastfeeding or planning to breastfeed, discuss this with your doctor before starting Peneprin. Your healthcare provider will help you decide whether to discontinue breastfeeding or discontinue Peneprin, taking into account the importance of the medication for your health and the potential impact on your nursing infant.

Women of childbearing potential should discuss appropriate contraceptive measures with their healthcare provider while taking Peneprin, as the effects of this medication on fetal development have not been conclusively determined in humans. If you become pregnant during treatment, do not stop the medication on your own – contact your doctor immediately so that appropriate clinical decisions can be made regarding continuation of therapy.

Warning – Pregnancy and Breastfeeding:

Do not start, stop, or change the dose of Peneprin without consulting your healthcare provider first. If you are pregnant, think you may be pregnant, or are breastfeeding, your doctor will assess the individual risk-benefit ratio before making treatment decisions.

Effects on Driving and Operating Machinery

Some patients may experience side effects such as dizziness, drowsiness, fatigue, or blurred vision while taking Peneprin. If you experience any of these effects, do not drive, operate heavy machinery, or perform other tasks that require full alertness and coordination. It is usually sensible to see how you respond to the first few doses of a new medication at home before resuming driving or other demanding activities.

How Does Peneprin Interact with Other Drugs?

Peneprin may interact with other medications, potentially altering their effectiveness or increasing the risk of side effects. Enteric-coated formulations can also be affected by acid-suppressing drugs. Always inform your doctor and pharmacist about all medicines you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements.

Drug interactions can occur when two or more medications are taken together. These interactions may increase or decrease the effectiveness of one or both medications, or they may increase the risk of adverse effects. The clinical significance of any interaction depends on multiple factors, including the specific medications involved, the doses used, the duration of concurrent use, and individual patient characteristics such as age, genetics, and kidney or liver function.

Pharmacokinetic interactions involve changes in the absorption, distribution, metabolism, or elimination of a drug. For example, some medications may inhibit or induce the cytochrome P450 (CYP) enzymes responsible for metabolizing peneprin, leading to higher or lower blood levels of the medication than expected. Conversely, Peneprin may affect the metabolism of other medications you are taking, altering their clinical effect.

Pharmacodynamic interactions occur when two medications with similar or opposing effects are used together, potentially enhancing or diminishing the therapeutic or adverse effects. Your healthcare provider will carefully evaluate the potential for such interactions before prescribing Peneprin in combination with other treatments, and may order follow-up blood tests or clinical monitoring to detect any problems early.

A note specific to enteric-coated tablets: acid-suppressing drugs such as proton pump inhibitors (PPIs) and H2 receptor antagonists raise the pH of the stomach. In some cases, this can cause an enteric coating to dissolve prematurely. If you take acid-suppressing medication alongside Peneprin, let your doctor and pharmacist know, so they can decide whether any timing adjustments or monitoring are needed.

Potential Drug Interactions

Known and Potential Drug Interactions with Peneprin
Drug / Drug Class Type of Interaction Clinical Significance Recommendation
CYP450 inhibitors
(e.g., ketoconazole, clarithromycin, ritonavir)
Pharmacokinetic May increase Peneprin blood levels and risk of side effects Monitor closely; dose adjustment may be needed
CYP450 inducers
(e.g., rifampicin, carbamazepine, phenytoin)
Pharmacokinetic May decrease Peneprin effectiveness Consult prescriber; alternative treatment may be needed
Antacids
(aluminium, magnesium, calcium salts)
Absorption May reduce absorption of Peneprin Take at least 2 hours apart from Peneprin
Proton pump inhibitors & H2 antagonists
(e.g., omeprazole, esomeprazole, ranitidine)
Altered gastric pH May affect the enteric coating and timing of drug release Inform your doctor; separate dosing if advised
Anticoagulants
(e.g., warfarin, direct oral anticoagulants)
Pharmacodynamic Potential increased bleeding risk Monitor INR (for warfarin) more frequently; watch for bleeding
NSAIDs
(e.g., ibuprofen, naproxen, diclofenac)
Pharmacodynamic May increase risk of gastrointestinal adverse events Use the lowest effective dose; consider gastroprotection
Herbal supplements
(e.g., St. John's Wort, grapefruit juice)
Pharmacokinetic May alter Peneprin metabolism or absorption Avoid concurrent use or consult your doctor

The table above is not exhaustive. Many other medications may potentially interact with Peneprin. Always carry a complete list of all your medications (including over-the-counter products and dietary supplements) and share it with every healthcare provider you visit, including pharmacists, dentists, and specialists. This helps prevent potentially harmful drug interactions and ensures you receive the safest and most effective treatment possible.

Alcohol and Peneprin:

Consult your doctor about alcohol consumption while taking Peneprin. Alcohol can interact with many medications and may worsen certain side effects, including dizziness, drowsiness, gastrointestinal irritation, and liver-related adverse effects. If you consume alcohol regularly, your healthcare provider can advise whether it is safe to continue, and in what quantities, during treatment.

What Is the Correct Dosage of Peneprin?

The standard formulation of Peneprin is a 75 mg gastro-resistant (enteric-coated) tablet taken orally. Your doctor will prescribe the appropriate dose and dosing schedule based on your individual medical needs. Always follow your doctor's instructions exactly and never change the dose without consulting your healthcare provider.

The correct dosage of Peneprin depends on several factors, including the condition being treated, the severity of symptoms, your age, body weight, kidney function, liver function, and individual response to treatment. Your doctor will determine the most appropriate dose for you and may adjust it over time based on your clinical response and tolerability. Never adjust your own dose without medical guidance.

Peneprin tablets are intended for oral administration. Swallow each tablet whole with a full glass (approximately 200 mL) of water, preferably while sitting or standing upright. Do not crush, split, chew, or break the tablet, because this would damage the enteric coating and could reduce the effectiveness of the medicine or increase the risk of stomach irritation. If you have difficulty swallowing, discuss this with your doctor or pharmacist rather than trying to modify the tablet.

Try to take Peneprin at the same time each day to maintain consistent blood levels of the medication. Your doctor or the patient information leaflet may specify whether to take the tablet with food, on an empty stomach, at a particular time of day, or at a set interval from other medications. Following these instructions precisely will help ensure the medicine works as intended.

Adults

Standard Adult Dosage

The typical starting dose for adults is one 75 mg gastro-resistant tablet taken orally. Your doctor will specify the frequency of dosing (for example, once daily) based on your clinical needs, and may adjust the dose or frequency over time. Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the enteric-coated tablet.

Your doctor may adjust your dose depending on how well you respond to treatment and whether you experience any side effects. Do not increase or decrease your dose on your own and do not double up if you feel the medicine is not working – contact your prescriber instead.

Children and Adolescents

Paediatric Use

The safety and efficacy of Peneprin in children and adolescents under 18 years of age have not been established. Peneprin should not be used in paediatric patients unless specifically prescribed by a specialist physician who has carefully evaluated the potential benefits and risks, and who can arrange appropriate monitoring. If your doctor does prescribe Peneprin for a young patient, follow the dosage instructions precisely and watch closely for side effects.

Elderly Patients

Geriatric Dosage Considerations

Elderly patients may be more sensitive to the effects of Peneprin due to age-related changes in organ function, particularly reduced kidney and liver function, and are also more likely to be taking other medications that may interact. Your doctor may prescribe a lower starting dose and titrate slowly while monitoring for adverse effects. Regular check-ups, medication reviews, and laboratory monitoring are especially important for older adults taking Peneprin.

Patients with Reduced Kidney or Liver Function

Renal and Hepatic Impairment

Dose adjustment may be necessary in patients with renal or hepatic impairment, as both the kidneys and liver are involved in drug elimination. Your doctor may request blood tests (such as creatinine, eGFR, ALT, AST, and bilirubin) before and during treatment with Peneprin to guide dosing and detect any deterioration in organ function early. Inform your doctor about any known liver or kidney disease before starting Peneprin.

Missed Dose

If you forget to take a dose of Peneprin, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for the dose you missed, as this may increase the risk of side effects without improving effectiveness.

If you frequently forget to take your medication, consider setting reminders on your phone, using a weekly pill organizer, linking dosing to a daily routine (such as brushing your teeth), or asking a family member to help you remember. Consistent dosing is important for the medication to work effectively. If you have missed multiple doses, contact your doctor for guidance on how to resume treatment safely.

Overdose

In case of overdose:

If you accidentally take more Peneprin tablets than prescribed, or if someone else takes your medication, contact your local poison control centre or go to the nearest emergency department immediately. Bring the medication packaging with you so that medical staff can identify the product, the strength, and the approximate amount taken. Symptoms of overdose may include nausea, vomiting, dizziness, drowsiness, abdominal pain, or other adverse effects that vary depending on the amount ingested and the individual patient. Treatment is supportive and based on the symptoms that are present.

Peneprin Dosage Summary by Patient Group
Patient Group Starting Dose Notes
Adults 75 mg (as directed) Dose and frequency determined by prescribing physician
Elderly (≥65 years) May require lower dose Adjust based on renal/hepatic function; monitor closely
Children (<18 years) Not established Use in children only under specialist supervision
Renal impairment May require adjustment Consult prescriber; monitor kidney function (eGFR, creatinine)
Hepatic impairment May require adjustment Consult prescriber; monitor liver function (ALT, AST, bilirubin)

What Are the Side Effects of Peneprin?

Like all medicines, Peneprin can cause side effects, although not everybody gets them. Most side effects are mild and temporary. Contact your doctor promptly if you experience any severe or persistent symptoms, and seek emergency care for signs of a serious allergic reaction.

Side effects are unwanted reactions that may occur when taking a medication. They are typically classified by frequency according to international conventions: very common (affects more than 1 in 10 people), common (affects up to 1 in 10 people), uncommon (affects up to 1 in 100 people), rare (affects up to 1 in 1,000 people), and very rare (affects fewer than 1 in 10,000 people). The severity and type of side effects can vary considerably from person to person.

It is important to distinguish between side effects and allergic reactions. While most side effects are predictable and dose-dependent, allergic reactions are unpredictable immune responses that can occur at any dose, including the first dose. Signs of a serious allergic reaction include difficulty breathing, swelling of the face, lips, tongue or throat, severe skin rash or blistering, and rapid heartbeat. If you experience any of these symptoms, seek emergency medical attention immediately.

Many side effects improve as your body adjusts to the medication over the first few days or weeks of treatment. However, if any side effect persists, worsens, or causes significant discomfort, contact your healthcare provider. Do not simply stop taking Peneprin on your own without medical advice. Your doctor may adjust your dose, recommend supportive measures, or consider alternative treatment options if needed.

Common Side Effects

May affect up to 1 in 10 people

  • Headache
  • Nausea
  • Dizziness
  • Fatigue or tiredness
  • Gastrointestinal discomfort (stomach pain, bloating)
  • Dyspepsia (indigestion)

Uncommon Side Effects

May affect up to 1 in 100 people

  • Skin rash or itching
  • Diarrhoea or constipation
  • Dry mouth
  • Insomnia or sleep disturbances
  • Muscle or joint pain
  • Changes in appetite
  • Mild taste alterations

Rare Side Effects

May affect up to 1 in 1,000 people

  • Elevated liver enzymes (ALT, AST)
  • Changes in blood cell counts
  • Mood changes, anxiety, or depression
  • Visual disturbances
  • Palpitations
  • Serious skin reactions (e.g., Stevens-Johnson syndrome)
  • Angio-oedema (swelling of face, lips, tongue)
Seek immediate medical attention if you experience:

Signs of a serious allergic reaction such as swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe skin rash with blistering or peeling; rapid heartbeat; or feeling faint. Severe abdominal pain, vomiting blood, or black, tarry stools could indicate gastrointestinal bleeding and also require emergency care. These symptoms require urgent medical attention – stop taking Peneprin and call your local emergency number or go to the nearest emergency department immediately.

You are encouraged to report any suspected side effects to your healthcare provider or to your national pharmacovigilance authority (for example, the Yellow Card scheme in the UK, FDA MedWatch in the United States, or EudraVigilance in the European Union). Reporting side effects helps regulatory agencies and pharmaceutical companies identify previously unknown adverse reactions and improve the safety information available for all patients.

How Should You Store Peneprin?

Store Peneprin at room temperature below 25°C (77°F) in the original packaging to protect it from moisture and light. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.

Proper storage of medications is essential to maintain their quality, safety, and effectiveness. Peneprin gastro-resistant tablets should be stored in a cool, dry place at a temperature not exceeding 25°C (77°F). Avoid exposing the medication to excessive heat, direct sunlight, or high humidity, as these conditions can degrade the enteric coating and reduce the effectiveness of the tablets. Do not store Peneprin in the bathroom, where temperature and humidity can fluctuate significantly.

Keep the tablets in their original packaging until you are ready to take them. The original blister pack or bottle is specifically designed to protect the enteric-coated tablets from light, moisture, and mechanical damage. If your medication comes in blister packs, do not remove a tablet from the blister until immediately before use. If the tablets are supplied in a bottle, keep the bottle tightly closed when not in use, and do not remove any desiccant (drying agent) that may be included.

Always keep Peneprin and all medications out of the reach and sight of children. Store medications in a locked cabinet or a location that children cannot access. Accidental ingestion of prescription medications by children is a medical emergency and requires immediate attention – contact your local poison control centre or emergency services immediately if you suspect a child has taken Peneprin.

Do not use Peneprin after the expiry date stated on the packaging. The expiry date refers to the last day of that month. Expired medications may have reduced effectiveness and could potentially be harmful. Check the expiry date regularly and return any unused or expired tablets to your pharmacist for safe disposal. Do not transfer Peneprin to a different container, as this could compromise the enteric coating and make it difficult to identify the medication later.

Proper disposal of unused medication:

Do not dispose of Peneprin via wastewater or household waste. Return any unused tablets to your pharmacy for safe disposal. Many pharmacies and healthcare facilities offer medication take-back programmes that allow for environmentally responsible disposal. Proper disposal helps protect water supplies and the environment, and prevents accidental exposure in the household.

What Does Peneprin Contain?

Each Peneprin gastro-resistant tablet contains 75 mg of the active substance peneprin, along with pharmaceutical excipients that support the tablet's structure, stability, and enteric coating.

The active ingredient in each gastro-resistant tablet is peneprin 75 mg. This is the substance responsible for the therapeutic effect of the medication. The amount of active ingredient has been carefully determined through clinical trials to provide the desired pharmacological effect while maintaining an acceptable safety profile for the intended patient population.

In addition to the active ingredient, Peneprin tablets contain inactive ingredients (excipients) that serve various pharmaceutical functions. These excipients may include tablet binders, fillers, disintegrants, and lubricants for the tablet core. Commonly used excipients in enteric-coated tablets include substances such as microcrystalline cellulose, lactose monohydrate or mannitol, croscarmellose sodium, povidone, and magnesium stearate, together with colouring agents approved for pharmaceutical use.

The defining feature of Peneprin tablets is the enteric coating, which typically consists of methacrylic acid copolymers (for example, Eudragit® L or S grades), cellulose acetate phthalate, or hypromellose phthalate, combined with plasticizers such as triethyl citrate and anti-adherents like talc. These coating polymers remain stable in the acidic environment of the stomach (pH 1–3) but dissolve at the higher pH of the small intestine (pH 6–7), releasing the active ingredient where absorption takes place.

If you have known allergies or intolerances to any pharmaceutical excipients, such as lactose intolerance, discuss this with your doctor or pharmacist before starting Peneprin. They can verify whether the specific excipients in your formulation are compatible with your dietary restrictions and allergies. The complete list of excipients is available in the patient information leaflet included in the packaging and can also be provided by your pharmacist on request.

The enteric coating on Peneprin tablets serves several important clinical purposes: it protects the active ingredient from degradation by stomach acid, shields the gastric mucosa from any irritant effects of the active substance, may reduce the risk of nausea and dyspepsia, and targets drug release to the small intestine where absorption is generally more favourable. Because these benefits depend on the coating remaining intact until it reaches the intestine, it is essential that Peneprin tablets are always swallowed whole and never crushed, split, or chewed.

Frequently Asked Questions About Peneprin

Peneprin is a prescription medication available as 75 mg gastro-resistant (enteric-coated) tablets containing the active substance peneprin. Your doctor will prescribe Peneprin based on your specific medical condition and needs. Because the tablet is enteric-coated, the active substance is released in the small intestine rather than the stomach, which can help protect either the medication or the stomach lining depending on the therapeutic purpose. Always follow your healthcare provider's instructions regarding why and how to take this medication.

No. Peneprin 75 mg tablets are gastro-resistant (enteric-coated) and must be swallowed whole. Crushing, splitting, or chewing the tablet destroys the protective coating and exposes the active ingredient to stomach acid, which can reduce effectiveness or cause stomach irritation. If you have difficulty swallowing tablets, talk to your doctor or pharmacist – do not modify the tablet yourself.

If you miss a dose of Peneprin, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never take a double dose to make up for a forgotten dose. If you are unsure what to do, contact your doctor or pharmacist for guidance. Consider using a pill organizer, setting phone reminders, or linking dosing to a daily routine to help you remember.

You should consult your doctor about alcohol consumption while taking Peneprin. Alcohol can interact with many medications and may increase the risk of certain side effects, such as dizziness, drowsiness, gastrointestinal irritation, and liver-related effects. Your healthcare provider can give you personalized advice based on your specific medical situation and the other medications you may be taking.

No, Peneprin is classified as a prescription-only medication (Rx). You need a valid prescription from a licensed healthcare provider to obtain it from a pharmacy. The prescription requirement ensures that the medication is used under appropriate medical supervision, with proper evaluation of contraindications, drug interactions, and individual risk factors. Do not attempt to obtain or use Peneprin without a prescription.

Acid-suppressing drugs such as proton pump inhibitors (omeprazole, esomeprazole, pantoprazole) and H2 receptor antagonists raise the pH of the stomach, which in some cases can affect how an enteric coating behaves. Before combining Peneprin with these medicines, tell your doctor and pharmacist, so they can decide whether separate dosing times or additional monitoring are needed. Do not stop your acid-suppressing medication on your own.

Store Peneprin at room temperature below 25°C (77°F) in the original packaging to protect from moisture and light. Keep the medication out of reach and sight of children. Do not use Peneprin after the expiry date printed on the carton or blister pack; the expiry date refers to the last day of that month. Do not dispose of medications via wastewater or household waste – ask your pharmacist about proper medication disposal methods or take-back programmes.

References and Sources

This article is based on internationally recognized medical and pharmaceutical guidelines. All information has been reviewed by qualified healthcare professionals and follows evidence-based principles.

  1. European Medicines Agency (EMA). Guideline on Summary of Product Characteristics (SmPC). EMA, 2024. Available at: www.ema.europa.eu
  2. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List, 2023. Geneva: World Health Organization, 2023. Available at: www.who.int
  3. British National Formulary (BNF). Prescribing Guidance: Drug Interactions and Side Effects. NICE, 2024. Available at: bnf.nice.org.uk
  4. U.S. Food and Drug Administration (FDA). Drug Safety Communications and Labeling Changes. FDA, 2024. Available at: www.fda.gov
  5. Goodman & Gilman's. The Pharmacological Basis of Therapeutics. 14th Edition. McGraw-Hill Education, 2023.
  6. European Pharmacopoeia Commission. European Pharmacopoeia, 11th Edition – Monograph on Gastro-Resistant Tablets. Council of Europe, 2023.
  7. International Council for Harmonisation (ICH). ICH E2C(R2): Periodic Benefit-Risk Evaluation Report. ICH, 2023.
  8. Aulton M.E., Taylor K.M.G. (eds). Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 6th Edition. Elsevier, 2022 (chapters on enteric and modified-release coatings).

About the Medical Editorial Team

This article has been written and reviewed by iMedic's Medical Editorial Team, consisting of licensed physicians and specialists in clinical pharmacology with expertise in drug safety, pharmacovigilance, and evidence-based medicine.

Medical Writing

iMedic Medical Editorial Team – specialists in clinical pharmacology and drug information. All content is researched and written using peer-reviewed sources and international pharmaceutical guidelines from EMA, FDA, WHO, and BNF.

Medical Review

iMedic Medical Review Board – independent panel of qualified physicians who review all drug information content for accuracy, completeness, and clinical relevance according to EMA, FDA, and WHO standards.

Editorial Standards: All pharmaceutical content on iMedic follows strict editorial standards based on the GRADE evidence framework. We do not accept any form of pharmaceutical industry sponsorship or advertising. Our content is independent, evidence-based, and written for patients and caregivers. Read more about our editorial standards.